Daniela Cavalleri Email & Phone Number

Experienced, dynamic, highly motivated Global Clinical Development Manager and Project leader, +20 years in global veterinary pharmaceutical companies. DVM, PhD, MSc; skilled in Veterinary drugs’ and feed additives development, Project management, Regulatory Affairs and Pharmacovigilance. Multi-lingual: English, German, Italian and French. Strong scientific expertise and communication, organizational and analytical skills. Excellent negotiation skills, with internal and external (e.g. Health Authorities) stakeholders. Good team player with ability to lead and collaborate in global, multifunctional project teams. Strong goal orientation and drive. Achievements:• Successfully developed and launched companion animals’ veterinary drugs.• Designed, led, implemented, development efficacy strategies; challenged Health Authorities requests with strong scientific arguments, achieving best possible label at registration, reducing costs/resources/timelines. • Designed, managed and executed efficacy programs and (GCP) experimental studies internally or performed by third parties.• Improved geographical efficiencies, optimized study design and leveraged pilot data, to reduce number of registration studies, promoting time- and cost- savings.• Identified risks and possible Health Authorities challenges and addressed them proactively.• Strategically designed project plans. Proactively and timely identified/addressed risks and challenges through fast strategy revisions. • Discussed project plans with senior management and regulatory agencies, obtaining agreement on main proposals, allowing between-regions efficiencies, reduced data package, costs and time to market. • Impacted strategic decisions and drove strategy re-assessments for a more profitable life cycle management.• Assessed current and prospective market gaps, merging scientific thinking and business needs.• Promoted the termination of an early development project not bringing the expected results, allowing the re-direction of resources to more promising and meaningful programs.• Major contributor to the design of a new, non-product specific, internal project, aimed at improving time, costs, efficiency and flexibility of early development projects.• Led introduction of GCP at a Company R&D site, allowing internal performance of registration studies, with significant costs and time savings.•Author of several scientific publications and social media articles.•Speaker at KOL Meetings.•International Conferences/Working Groups abstracts author.•Speaker at International Congresses.

Listed skills include Regulatory Affairs, Clinical Development, Clinical Trials, Drug Development, and 10 others.